Research Article

Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis

Volume: 6 Number: 1 February 14, 2025
TR EN

Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis

Abstract

Aims: Hashimoto's thyroiditis (HT) is the most common autoimmune thyroid disorder and a leading cause of hypothyroidism worldwide. This bibliometric analysis aims to provide a comprehensive overview of HT research trends, key contributors, and emerging themes by evaluating 1.309 articles published between 2004 and 2023. The study seeks to identify gaps, highlight advancements, and offer insights to guide future research efforts. Methods: Data were collected from the Web of Science Core Collection database using the keyword "Hashimoto" and filtered by the "endocrinology metabolism" category. Bibliometric analysis was conducted using VOSviewer to visualize publication trends, keyword relationships, and collaboration networks. Citation metrics and publication outputs were analyzed to identify influential contributors and emerging research themes. Results: The analysis revealed a steady growth in publications, peaking in 2021, with notable contributions from leading institutions and journals such as thyroid and Journal of Clinical Endocrinology & Metabolism. Dominant themes included autoimmune mechanisms, thyroid dysfunction, and the gut-thyroid axis. Emerging areas, such as microbiota-targeted interventions and personalized medicine, offer promising avenues for advancing HT research. However, regional disparities and conflicting findings in treatment strategies, including dietary interventions and supplementation, underscore the need for more robust studies. Conclusion: HT research has achieved significant progress in understanding its pathogenesis and clinical management. Future efforts should focus on multidisciplinary, large-scale studies that integrate advanced technologies and address regional research gaps. By fostering global collaborations and embracing innovative approaches, the scientific community can improve patient outcomes and advance the field of HT research.

Keywords

Ethical Statement

Since this research is a bibliometric study, it did not require ethics committee approval. It is conducted with the institution's permission.

Thanks

I would like to thank Gizem Çoban for her support during the analysis and data visualization stages.

References

  1. Sawin CT. History of Hashimoto’s disease: the heritage of Dr. Hakaru Hashimoto (1881-1934). Endocr J. 2002;49(4):399-403. doi:10.1507/endocrj.49.399
  2. Ahmed R, Al-Shaikh S, Akhtar M. Hashimoto thyroiditis: a century later. Adv Anat Pathol. 2012;19(3):181-126. doi:10.1097/PAP.0b013e 3182534868
  3. Zaletel K, Gaberscek S. Hashimoto's thyroiditis: from genes to the disease. Curr Genomics. 2011;12(8):576-588. doi:10.2174/138920211798120763
  4. Radetti G. Clinical aspects of Hashimoto's thyroiditis. Endocr Dev. 2014; 26:158-170. doi:10.1159/000363162
  5. Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol Arch Intern Med. 2022;132(3):16222. doi:10.20452/pamw.16222
  6. Akamizu T, Amino N. Hashimoto’s Thyroiditis. In: Endotext. MDText.com, Inc., South Dartmouth (MA); 2000.
  7. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. doi:10.1016/j.autrev.2014.01.007
  8. Kessler MM. Bibliographic coupling between scientific papers. Am Doc. 1963;14(1):10-25. doi:10.1002/asi.5090140103

Details

Primary Language

English

Subjects

Endocrinology

Journal Section

Research Article

Publication Date

February 14, 2025

Submission Date

January 4, 2025

Acceptance Date

February 9, 2025

Published in Issue

Year 2025 Volume: 6 Number: 1

APA
Alarslan, P. (2025). Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis. Journal of Medicine and Palliative Care, 6(1), 57-65. https://doi.org/10.47582/jompac.1613141
AMA
1.Alarslan P. Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis. J Med Palliat Care / JOMPAC / jompac. 2025;6(1):57-65. doi:10.47582/jompac.1613141
Chicago
Alarslan, Pınar. 2025. “Advancements and Challenges in Hashimoto’s Thyroiditis Research: A Bibliometric Analysis”. Journal of Medicine and Palliative Care 6 (1): 57-65. https://doi.org/10.47582/jompac.1613141.
EndNote
Alarslan P (February 1, 2025) Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis. Journal of Medicine and Palliative Care 6 1 57–65.
IEEE
[1]P. Alarslan, “Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis”, J Med Palliat Care / JOMPAC / jompac, vol. 6, no. 1, pp. 57–65, Feb. 2025, doi: 10.47582/jompac.1613141.
ISNAD
Alarslan, Pınar. “Advancements and Challenges in Hashimoto’s Thyroiditis Research: A Bibliometric Analysis”. Journal of Medicine and Palliative Care 6/1 (February 1, 2025): 57-65. https://doi.org/10.47582/jompac.1613141.
JAMA
1.Alarslan P. Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis. J Med Palliat Care / JOMPAC / jompac. 2025;6:57–65.
MLA
Alarslan, Pınar. “Advancements and Challenges in Hashimoto’s Thyroiditis Research: A Bibliometric Analysis”. Journal of Medicine and Palliative Care, vol. 6, no. 1, Feb. 2025, pp. 57-65, doi:10.47582/jompac.1613141.
Vancouver
1.Pınar Alarslan. Advancements and challenges in Hashimoto’s thyroiditis research: a bibliometric analysis. J Med Palliat Care / JOMPAC / jompac. 2025 Feb. 1;6(1):57-65. doi:10.47582/jompac.1613141

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"